These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19245908)

  • 1. Incidental thyroid nodule: patterns of diagnosis and rate of malignancy.
    Jin J; Wilhelm SM; McHenry CR
    Am J Surg; 2009 Mar; 197(3):320-4. PubMed ID: 19245908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management of incidental thyroid nodules in patients with another primary malignancy.
    Wilhelm SM; Robinson AV; Krishnamurthi SS; Reynolds HL
    Surgery; 2007 Oct; 142(4):581-6; discussion 586-7. PubMed ID: 17950351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental PET/CT findings in the cancer patient: how should they be managed?
    Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
    Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid disorders: evaluation and management of thyroid nodules.
    Cohen JI; Salter KD; ; ;
    Oral Maxillofac Surg Clin North Am; 2008 Aug; 20(3):431-43. PubMed ID: 18603201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign and Malignant Thyroid Incidentalomas Are Rare in Routine Clinical Practice: A Review of 97,908 Imaging Studies.
    Uppal A; White MG; Nagar S; Aschebrook-Kilfoy B; Chang PJ; Angelos P; Kaplan EL; Grogan RH
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1327-31. PubMed ID: 26160694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index in the evaluation of thyroid cancer risk.
    Mijović T; How J; Pakdaman M; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Tamilia M; Payne RJ
    Thyroid; 2009 May; 19(5):467-72. PubMed ID: 19415996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of thyroid nodules in patients with primary hyperparathyroidism.
    Wang TS; Roman SA; Cox H; Air M; Sosa JA
    J Surg Res; 2009 Jun; 154(2):317-23. PubMed ID: 19201427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of thyroid incidentaloma.
    Wilhelm S
    Surg Clin North Am; 2014 Jun; 94(3):485-97. PubMed ID: 24857572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cyto-histological correlation of malignant thyroid nodules: clinical factors as predictors of malignancy].
    Allen M; Sapinho I; Raposo L; Torrinha J
    Acta Med Port; 2008; 21(2):135-40. PubMed ID: 18625092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in predicting thyroid malignancy.
    Stang MT; Carty SE
    Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid incidentalomas.
    Pinchera A
    Horm Res; 2007; 68 Suppl 5():199-201. PubMed ID: 18174746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is nodule size an independent predictor of thyroid malignancy?
    McHenry CR; Huh ES; Machekano RN
    Surgery; 2008 Dec; 144(6):1062-8; discussion 1068-9. PubMed ID: 19041019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant cancer rates in incidentally discovered thyroid nodules by routine imaging.
    Farrá JC; Picado O; Liu S; Ouyang W; Teo R; Franco AM; Lew JI
    J Surg Res; 2017 Nov; 219():341-346. PubMed ID: 29078903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Mount Sinai to Mount Scopus: differences in the role and value of fine needle aspiration for evaluating thyroid nodules.
    Mazeh H; Greenstein A; Swedish K; Arora S; Hermon H; Ariel I; Divino C; Freund HR; Weber K
    Isr Med Assoc J; 2009 May; 11(5):291-5. PubMed ID: 19637507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive index for carcinoma of thyroid nodules and its integration with fine-needle aspiration cytology.
    Kuru B; Gulcelik NE; Gulcelik MA; Dincer H
    Head Neck; 2009 Jul; 31(7):856-66. PubMed ID: 19340874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis as a benign cause of lymphadenopathy in cancer patients.
    Hunt BM; Vallières E; Buduhan G; Aye R; Louie B
    Am J Surg; 2009 May; 197(5):629-32; discussion 632. PubMed ID: 19321155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of pulmonary nodules and lung cancer with one-inch crystal gamma coincidence positron emission tomography/CT versus dedicated positron emission tomography/CT.
    Moodie K; Cherk MH; Lau E; Turlakow A; Skinner S; Hicks RJ; Kelly MJ; Kalff V
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):32-9. PubMed ID: 19453526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to do with incidental thyroid nodules on imaging? An approach for the radiologist.
    Hoang JK; Raduazo P; Yousem DM; Eastwood JD
    Semin Ultrasound CT MR; 2012 Apr; 33(2):150-7. PubMed ID: 22410363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of palpable thyroid nodule in Isfahan, Iran, 2006: a population based study.
    Parham M; Aminorroaya A; Amini M
    Exp Clin Endocrinol Diabetes; 2009 May; 117(5):209-13. PubMed ID: 19053026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.